Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2023 | HPV vaccination and its potential impact on the incidence of penile cancer

Maarten Albersen • 17 Feb 2023
GU Cancers 2023
Cervical Cancer Genitourinary Cancer Head and Neck Cancer Penile Cancer Rectal Cancer

Maarten Albersen, MD, PhD, University Hospitals Leuven, Leuven, Belgium, discusses the human papillomavirus (HPV) vaccine and its potential impact on the incidence of penile cancer. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Maarten Albersen

1:08
Highlights in penile cancer at ASCO GU 2023
Maarten Albersen • 17 Feb 2023
1:16
Unmet needs for penile cancer
Maarten Albersen • 17 Feb 2023
0:58
Does the treatment of penile cancer differ in patients with HPV compared to those without?
Maarten Albersen • 17 Feb 2023
1:13
Human papillomavirus (HPV) and the development of penile cancer
Maarten Albersen • 17 Feb 2023

Related Videos

0:57
Real-world outcomes of 177Lu-PSMA-617 in mCRPC
Hannah McManus • 8 Apr 2024
0:38
Emerging combinatory immunotherapies show promise for mCRPC
Hannah McManus • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals